100 results on '"Lidereau R"'
Search Results
2. Modification of the Regulation of Interleukin 2 (IL2) in Human Breast Cancer
3. INTERLEUKIN 2 (IL2) PRODUCTION BY LYMPHOCYTES OF HUMAN BREAST CANCER PATIENTS
4. Comparison between Glycolytic Enzyme Activities in Benign and Malignant Breast Tumors
5. The Current Status of int Genes, Proto-Oncogenes, and Recessive Mutations in Primary Human Breast Tumors: Their Potential Usefulness in Prognosis
6. Lack of referral for genetic counseling and testing in BRCA1/2 and Lynch syndromes: a nationwide study based on 240,134 consultations and 134,652 genetic tests
7. Identification d’une signature moléculaire de 3-miARNs predictive de l’aggressivité et du pronostic des tumeurs de vessie infiltrant le muscle
8. MDGI, MIG-6 et EIG121 sont des inhibiteurs de la voie EGFR et des biomarqueurs potentiels de thérapies ciblées anti-EGFR dans les carcinomes mammaires invasifs
9. Rare germline large rearrangements in the BRCA1/2 genes and eight candidate genes in 472 patients with breast cancer predisposition
10. 115 A Diagnostic Genetic Test for the Physical Mapping of Germline Rearrangements in the Susceptibility Breast Cancer Genes BRCA1 and BRCA2
11. Hedgehog pathway activation in human transitional cell carcinoma of the bladder
12. 169 MicroRNA expression profile in a large series of bladder tumors: Identification of a 3-miRNA signature predictive of aggressiveness and prognosis of muscle-invasive bladder cancer
13. Identification of New Candidate Therapeutic Target Genes in Triple-Negative Breast Cancer
14. P1-05-03: Relationship between Polycomb Repressive Complex EZH2/CBX7, Large Non-Coding RNA ANRIL and Stem Cells Biomarkers in Triple Negative Breast Carcinomas: Important Role in Carcinogenesis through an Epigenetic Silencing Process and New Clues for Targeted Therapies.
15. P2-13-10: Detection, Visualization and High Resolution Physical Mapping of Large Rearrangements by Molecular Combing in the Hereditary Breast Cancer Genes BRCA1 and BRCA2.
16. Rôles du complexe répresseur Polycomb EZH2/CBX7 et du long ARN non codant ANRIL dans l’induction des mécanismes de silencing épigénétique. Implications thérapeutiques potentielles dans les carcinomes mammaires de type triple négatif
17. First large rearrangement in the MUTYH gene and attenuated familial adenomatous polyposis syndrome
18. A refined molecular taxonomy of breast cancer
19. Up-regulation of a set of genes in breast cancer bone metastases discloses predisposition to generate metastases also in visceral organs
20. Delineation of molecular subgroups of breast cancer with distinct genomic profiles and different clinical courses: a novel definition of disease subclasses
21. Germline APC mutation spectrum derived from 863 genomic variations identified through a 15-year medical genetics service to French patients with FAP
22. Ceramide galactosyltransferase (UGT8) is a molecular marker of breast cancer malignancy and lung metastases
23. 799 Molecular subgroups of breast cancer show distinct genomic profiles and different clinical courses: a novel definition of disease subclasses
24. MicroRNA Expression Profiling of Inflammatory Breast Cancer.
25. Inhibition of the Wnt/β-catenin pathway by the WWOX tumor suppressor protein
26. DNA repair gene expression profile and risk of locoregional relapse in locally advanced breast cancer patients
27. KRAS mutation status in colorectal cancer to predict response to EGFR targeted therapies: the need for a more precise definition
28. mTOR inhibition reverses acquired endocrine therapy resistance of breast cancer cells at the cell proliferation and gene expression levels
29. Candidate molecular markers associated with endocrine resistance in breast carcinoma
30. Screening BRCA1 and BRCA2 unclassified variants for splicing mutations using reverse transcription PCR on patient RNA and an ex vivo assay based on a splicing reporter minigene
31. HEDGEHOG PATHWAY INVOLVEMENT IN BLADDER CARCINOGENESIS: A STUDY OF 71 PATIENTS
32. MRNA EXPRESSION LEVELS AND PROGNOSTIC VALUE OF 40 ANGIOGENIC GENES IN A LARGE SERIES OF 157 BLADDER TUMOURS
33. ABCC11 expression is regulated by estrogen in MCF7 cells, correlated with estrogen receptor expression in postmenopausal breast tumors and overexpressed in tamoxifen-resistant breast cancer cells
34. CXC chemokines located in the 4q21 region are up-regulated in breast cancer
35. Oligonucleotide microarray analysis of estrogen receptor α-positive postmenopausal breast carcinomas: identification of HRPAP20 and TIMELESS as outstanding candidate markers to predict the response to tamoxifen
36. High‐resolution oligonucleotide array‐CGH applied to the detection and characterization of large rearrangements in the hereditary breast cancer gene BRCA1
37. The TLR4 polymorphism predicts the response of breast cancer patients to anthracyclins
38. Identification of novel genes that co-cluster with estrogen receptor alpha in breast tumor biopsy specimens, using a large-scale real-time reverse transcription-PCR approach
39. Transcriptome analysis reveals an osteoblast-like phenotype for human osteotropic breast cancer cells
40. Structural organization and expression of human MTUS1, a candidate 8p22 tumor suppressor gene encoding a family of angiotensin II AT2 receptor-interacting proteins, ATIP
41. A new genomic approach to describe the natural history of node negative breast cancer patients
42. Independent prognostic value of somatic TP53gene mutations in 1794 breast cancer patients
43. Trimodal GSTT1 and GSTM1 Genotyping Assay by Real-Time PCR
44. Molecular changes associated with the agonist activity of hydroxy-tamoxifen and the hyper-response to estradiol in hydroxy-tamoxifen-resistant breast cancer cell lines
45. Trimodal GSTT1 and GSTM1 genotyping assay by real-time PCR
46. Inter-laboratory quality control for hormone-dependent gene expression in human breast tumors using real-time reverse transcription-polymerase chain reaction
47. Real-time PCR-based gene dosage assay for detecting BRCA1 rearrangements in breast-ovarian cancer families
48. Detection of telomerase status by semiquantitative andin situassays, and by real-time reverse transcription-polymerase chain reaction (telomerase reverse transcriptase) assay in bladder carcinomas
49. Prognostic value of maspin mRNA expression in ERα-positive postmenopausal breast carcinomas
50. Un nouveau modèle de cancer humain de prostate, PAC120
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.